Overview

Test and Treat COVID 65plus+

Status:
Withdrawn
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
Patients over equal or older than 65 yearswill be treated with a hydroxychloroquine versus placebo reduced loading dose of 600mg on the first day followed with 400mg/day divided in 2x200mg for 6 more days resulting in a total duration of therapy of 7 days. Measurement of Hydroxychloroquine-levels will be performed on day 7, . A follow-up by video or telephone conference will be performed to observe drug intake and collect adverse events during treatment phase on a daily base on working days and once during the weekend (i.e. 6 out of 7 days). After treatment phase follow-up by telephone calls will be done on day 10, 30, 60 (+/- 2 days).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Hospital Tuebingen
Treatments:
Hydroxychloroquine